High impact for generic manufacturer Impax of first NDA for branded in-house drug
This article was originally published in Scrip
Executive Summary
Impax Laboratories Inc. will find out in October whether its branded product division, Impax Pharmaceuticals, will be able to market its first novel drug developed in-house.